7/4/2025

Janusmed amning

Janusmed amning – erytromycinestolat

Janusmed amning tillhandahåller generella rekommendationer om huruvida ett friskt fullgånget spädbarn kan ammas när modern använder olika läkemedel. Observera att prematura och/eller sjuka spädbarn alltid kräver särskilda överväganden. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed amning och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Erytromycin

Erytromycin

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Matsuda S. Transfer of antibiotics into maternal milk. Biol Res Pregnancy Perinatol. 1984;5(2):57-60.

  2. Zhang Y, Zhang Q, Xu Z. [Tissue and body fluid distribution of antibacterial agents in pregnant and lactating women]. Zhonghua Fu Chan Ke Za Zhi. 1997;32:288-92.

  3. Ito S, Blajchman A, Stephenson M, Eliopoulos C, Koren G. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol 1993; (168): 1393-1399.

  4. Sorensen HT, Skriver MV, Pedersen L et al. Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides. Scand J Infect Dis. 2003;35:104-6.

  5. Stang H. Pyloric stenosis associated with erythromycin ingested through breastmilk. Minn Med. 1986;69:669-70, 682.

  6. Goldstein LH, Berlin M, Tsur L, Bortnik O, Binyamini L, Berkovitch M. The safety of macrolides during lactation. Breastfeed Med. 2009;4:197-200.

  7. Mathew JL. Effect of maternal antibiotics on breast feeding infants. Postgrad Med J. 2004; 80(942):196-200.

  1. Matsuda S. Transfer of antibiotics into maternal milk. Biol Res Pregnancy Perinatol. 1984;5(2):57-60.
  2. Zhang Y, Zhang Q, Xu Z. [Tissue and body fluid distribution of antibacterial agents in pregnant and lactating women]. Zhonghua Fu Chan Ke Za Zhi. 1997;32:288-92.
  3. Ito S, Blajchman A, Stephenson M, Eliopoulos C, Koren G. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol 1993; (168): 1393-1399.
  4. Sorensen HT, Skriver MV, Pedersen L et al. Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides. Scand J Infect Dis. 2003;35:104-6.
  5. Stang H. Pyloric stenosis associated with erythromycin ingested through breastmilk. Minn Med. 1986;69:669-70, 682.
  6. Goldstein LH, Berlin M, Tsur L, Bortnik O, Binyamini L, Berkovitch M. The safety of macrolides during lactation. Breastfeed Med. 2009;4:197-200.
  7. Mathew JL. Effect of maternal antibiotics on breast feeding infants. Postgrad Med J. 2004; 80(942):196-200.

Innehållet senast uppdaterat 5/7/2025

2 2
2 2

Erytromycin

Erytromycin

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Matsuda S. Transfer of antibiotics into maternal milk. Biol Res Pregnancy Perinatol. 1984;5(2):57-60.

  2. Zhang Y, Zhang Q, Xu Z. [Tissue and body fluid distribution of antibacterial agents in pregnant and lactating women]. Zhonghua Fu Chan Ke Za Zhi. 1997;32:288-92.

  3. Ito S, Blajchman A, Stephenson M, Eliopoulos C, Koren G. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol 1993; (168): 1393-1399.

  4. Sorensen HT, Skriver MV, Pedersen L et al. Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides. Scand J Infect Dis. 2003;35:104-6.

  5. Stang H. Pyloric stenosis associated with erythromycin ingested through breastmilk. Minn Med. 1986;69:669-70, 682.

  6. Goldstein LH, Berlin M, Tsur L, Bortnik O, Binyamini L, Berkovitch M. The safety of macrolides during lactation. Breastfeed Med. 2009;4:197-200.

  7. Mathew JL. Effect of maternal antibiotics on breast feeding infants. Postgrad Med J. 2004; 80(942):196-200.

  1. Matsuda S. Transfer of antibiotics into maternal milk. Biol Res Pregnancy Perinatol. 1984;5(2):57-60.
  2. Zhang Y, Zhang Q, Xu Z. [Tissue and body fluid distribution of antibacterial agents in pregnant and lactating women]. Zhonghua Fu Chan Ke Za Zhi. 1997;32:288-92.
  3. Ito S, Blajchman A, Stephenson M, Eliopoulos C, Koren G. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol 1993; (168): 1393-1399.
  4. Sorensen HT, Skriver MV, Pedersen L et al. Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides. Scand J Infect Dis. 2003;35:104-6.
  5. Stang H. Pyloric stenosis associated with erythromycin ingested through breastmilk. Minn Med. 1986;69:669-70, 682.
  6. Goldstein LH, Berlin M, Tsur L, Bortnik O, Binyamini L, Berkovitch M. The safety of macrolides during lactation. Breastfeed Med. 2009;4:197-200.
  7. Mathew JL. Effect of maternal antibiotics on breast feeding infants. Postgrad Med J. 2004; 80(942):196-200.

Innehållet senast uppdaterat 5/7/2025